The Selective JAK1/3-Inhibitor R507 Mitigates Obliterative Airway Disease Both With Systemic Administration and Aerosol Inhalation

2016 ◽  
Vol 100 (5) ◽  
pp. 1022-1031 ◽  
Author(s):  
Tobias Deuse ◽  
Xiaoqin Hua ◽  
Mandy Stubbendorff ◽  
Joshua M. Spin ◽  
Evgenios Neofytou ◽  
...  
2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
J. Guihaire ◽  
R. Itagaki ◽  
T. Deuse ◽  
X. Hua ◽  
M. Stubbendorff ◽  
...  

2002 ◽  
Vol 74 (4) ◽  
pp. 557-562 ◽  
Author(s):  
Melissa B. King ◽  
Andrew C. Pedtke ◽  
Helene L. Levrey-Hadden ◽  
Marshall I. Hertz

2011 ◽  
Vol 30 (4) ◽  
pp. S119
Author(s):  
R. Preidl ◽  
S. Eckl ◽  
M. Ramsperger-Gleixner ◽  
N. Koch ◽  
M. Weyand ◽  
...  

2003 ◽  
Vol 22 (9) ◽  
pp. 1014-1022 ◽  
Author(s):  
Hanni S Alho ◽  
Ulla-Stina Salminen ◽  
Paula K Maasilta ◽  
Paavo Pääkkö ◽  
Ari L.J Harjula

2011 ◽  
Vol 37 (7) ◽  
pp. 435-444 ◽  
Author(s):  
Olin D. Liang ◽  
Bjoern E. Kleibrink ◽  
Katharina Schuette-Nuetgen ◽  
Umakanth U. Khatwa ◽  
Bechara Mfarrej ◽  
...  

2006 ◽  
Vol 34 (1) ◽  
pp. 108-118 ◽  
Author(s):  
Erin E. West ◽  
Tera L. Lavoie ◽  
Jonathan B. Orens ◽  
Edward S. Chen ◽  
Shui Q. Ye ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document